Ressource Scientifique
Blog
Blog
23/04/2026
Why Don’t Biomarkers Reliably Reflect Clinical Translatability in Inflammation?
Biological activity doesn’t always translate. Discover why functional readouts are critical in preclinical inflammation research.
Blog
14/04/2026
A Closer Look at Astatine-211 in Targeted Alpha Radiotherapy
Understanding astatine-211 in targeted alpha radiotherapy, from high LET precision to radiochemistry, supply, and study design constraints.
Blog
02/03/2026
Designing Robust In Vivo Bioluminescence Imaging Studies
Why substrate choice matters in bioluminescence imaging. Discover how study design decisions shape sensitivity, data quality, and biological insight.
Blog
02/03/2026
The Complexity Behind Modeling Endometriosis
Why is endometriosis so difficult to model preclinically? The biological and translational challenges behind the data.
Blog
27/02/2026
Functional Readouts as a Bridge Between Inflammation and Patient Experience
Why inflammation research must look beyond lesions to functional impact, with insights from dermatology, lung disease, and endometriosis.
Blog
24/02/2026
Alpha or Beta? Choosing the Right Emitter for Targeted Radiotherapy
What distinguishes alpha and beta emitters in targeted radiotherapy? How radiation range, LET, and radionuclide properties influence efficacy and development.
Blog
28/01/2026
Predicting Clinical Success in Preclinical Inflammatory Gut Disease Research
Insights into preclinical study design for inflammatory gut disease, covering acute vs chronic models, dosing strategies, and clinically relevant endpoints.
Blog
07/01/2026
TRT and Oncological Drugs Acting Together
Discover how targeted radiotherapy combined with oncological drugs is reshaping oncology through synergy, safety and precision medicine
Blog
15/10/2025
What Was Trending at EANM 2025
Terbium, astatine, actinium, combination therapies, pretargeting strategies... Here's what caught our attention, read the article
Blog
09/09/2025
How Screening Covalent Libraries Lands Hits Where Others Fail
Interview with an expert: learn why covalent screening is gaining traction in drug discovery and what makes it a powerful strategy for PPIs and more.
Ressource Scientifique
16/06/2025
How Humanized Models Advance Oncology Drug Development
A Q&A with Caroline on how humanized models have emerged as a game-changing tool in preclinical research.
Blog
10/06/2025
What Can Engineered Cells Tell You About Your Compound?
From signaling to surprises, reporter cell assays bring clarity to compound screening. Read the blog to find out what engineered cells can tell you.